Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

Deciphering the role of FOXA1 in diet-induced, obesity-dependent prostate cancer progression

EF 2020-21

Résumé
In Canada, prostate cancer remains a significant health burden, as it is the most common cancer among Canadian men. Notably, there is evidence that obesity, which can be driven by the consumption of high-fat foods, is associated with advanced prostate cancer. Understanding the molecular mechanism behind this association is of key importance, as it will help us to identify patients who are at risk for advanced prostate cancer, and it will help us to develop precision medicines for prostate cancer patients who are obese or who have these aggressive molecular profiles. Alterations in the tumour epigenome have been proposed as a potential mechanism linking diet-induced obesity and aggressive prostate cancer. Specifically, we are interested in the pioneer transcription factor forkhead box A1 protein (FOXA1) which is capable of eliciting epigenetic reprogramming and is frequently mutated in prostate cancer. Notably, preliminary data suggests that the epigenome of the cancer cells is modified during prostate cancer progression, particularly in areas associated with FOXA1 activity. These modifications are further exaggerated under conditions of diet-induced obesity. Therefore, we hypothesize that FOXA1 mediates diet-induced, obesity-dependent prostate cancer progression by inducing epigenetic reprogramming to favour cancer progression. To determine the role of FOXA1 in prostate cancer development, we will use a combination of in vitro and in vivo experiments, which will offer us insight into the role of epigenetic remodeling in the evolution of prostate cancer. This opens up the exciting possibility of leveraging epigenetic profiling in predicting patient responses to cancer treatment and in developing personalized, epigenome-based medicines.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
449546
Name
Shen Michelle
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Deciphering the role of FOXA1 in diet-induced, obesity-dependent prostate cancer progression
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Atac-Seq; Chip-Seq; Chromatin Remodelling; Dietary Modification; Epigenetic Regulation; Foxa1; Molecular Mechanism Of Disease Development And Progression; Mouse Models Of Disease Progression; Prostate Cancer; Rna-Seq
Abstract
In Canada, prostate cancer remains a significant health burden, as it is the most common cancer among Canadian men. Notably, there is evidence that obesity, which can be driven by the consumption of high-fat foods, is associated with advanced prostate cancer. Understanding the molecular mechanism behind this association is of key importance, as it will help us to identify patients who are at risk for advanced prostate cancer, and it will help us to develop precision medicines for prostate cancer patients who are obese or who have these aggressive molecular profiles. Alterations in the tumour epigenome have been proposed as a potential mechanism linking diet-induced obesity and aggressive prostate cancer. Specifically, we are interested in the pioneer transcription factor forkhead box A1 protein (FOXA1) which is capable of eliciting epigenetic reprogramming and is frequently mutated in prostate cancer. Notably, preliminary data suggests that the epigenome of the cancer cells is modified during prostate cancer progression, particularly in areas associated with FOXA1 activity. These modifications are further exaggerated under conditions of diet-induced obesity. Therefore, we hypothesize that FOXA1 mediates diet-induced, obesity-dependent prostate cancer progression by inducing epigenetic reprogramming to favour cancer progression. To determine the role of FOXA1 in prostate cancer development, we will use a combination of in vitro and in vivo experiments, which will offer us insight into the role of epigenetic remodeling in the evolution of prostate cancer. This opens up the exciting possibility of leveraging epigenetic profiling in predicting patient responses to cancer treatment and in developing personalized, epigenome-based medicines.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Shen, Michelle
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~